About Nectar Lifescience Ltd
Nectar Lifescience is engaged in Company undertook significant restructuring and asset monetization initiatives including slump sale/business transfer arrangements relating to certain manufacturing units/ business undertakings, monetization of identified land parcels and other non-core assets.
Founded
1995
CEO
Sanjiv Goyal
Employees
111
HQ
Chandigarh, India
Finished Products
1Sales
₹3,834.23CrRaw Materials
1Raw Materials Consumed
₹2,493.17CrAbout Nectar Lifescience Ltd
Nectar Lifescience is engaged in Company undertook significant restructuring and asset monetization initiatives including slump sale/business transfer arrangements relating to certain manufacturing units/ business undertakings, monetization of identified land parcels and other non-core assets.
Founded:1995
CEO:Sanjiv Goyal
Employees:111
HQ:Chandigarh, India
Finished Products
1Sales
₹3,834.23CrRaw Materials
1Raw Materials Consumed
₹2,493.17CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹22
52W Low
₹9
Volume306.97K
Avg VolumeN/A
Beta1.08
Dividend Yield0.00%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
-0.97x
Valuation
P/B Ratio
0.41x
Valuation
EPS
₹-12.61
Valuation
Dividend Yield
0.00%
Valuation
ROE
-9.85%
Profitability
ROCE
-8.75%
Profitability
Revenue by Segment
Contribution & growth by business line
Pharmaceuticals ProductsRevenue split N/A
Geographical Revenue Split
Domestic vs international exposure
Domestic
64.2%
International
35.8%
India64.2%
Outside India35.8%
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.00x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
3.1%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.